Dagui Lin

644 total citations
18 papers, 428 citations indexed

About

Dagui Lin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Dagui Lin has authored 18 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Dagui Lin's work include Cancer Immunotherapy and Biomarkers (7 papers), Ferroptosis and cancer prognosis (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Dagui Lin is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Ferroptosis and cancer prognosis (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Dagui Lin collaborates with scholars based in China, United States and Hong Kong. Dagui Lin's co-authors include Yunfang Yu, Yongjian Chen, Qiyun Ou, Herui Yao, Anlin Li, Haiyu Zhou, Shengbo Liu, Dongqiang Zeng, Wangjun Liao and Wenhua Fan and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Dagui Lin

15 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dagui Lin China 8 252 203 130 126 112 18 428
Xiliang Cong China 9 283 1.1× 150 0.7× 129 1.0× 112 0.9× 161 1.4× 14 479
Jun Osugi Japan 11 209 0.8× 104 0.5× 164 1.3× 110 0.9× 131 1.2× 31 412
Yuqiu Xu China 9 126 0.5× 123 0.6× 123 0.9× 110 0.9× 59 0.5× 18 288
Zhenkui Pan China 10 312 1.2× 302 1.5× 74 0.6× 80 0.6× 50 0.4× 12 423
Yunjian Huang China 9 217 0.9× 182 0.9× 65 0.5× 73 0.6× 48 0.4× 30 345
Yunfu Deng China 12 219 0.9× 105 0.5× 108 0.8× 118 0.9× 55 0.5× 20 402
Fucun Xie China 12 154 0.6× 147 0.7× 151 1.2× 110 0.9× 42 0.4× 29 386
Yueyun Chen China 9 170 0.7× 108 0.5× 71 0.5× 57 0.5× 62 0.6× 27 301
Maria Saigí Spain 10 172 0.7× 142 0.7× 203 1.6× 104 0.8× 66 0.6× 24 380
De Sen Wan China 9 247 1.0× 85 0.4× 119 0.9× 55 0.4× 150 1.3× 35 416

Countries citing papers authored by Dagui Lin

Since Specialization
Citations

This map shows the geographic impact of Dagui Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dagui Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dagui Lin more than expected).

Fields of papers citing papers by Dagui Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dagui Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dagui Lin. The network helps show where Dagui Lin may publish in the future.

Co-authorship network of co-authors of Dagui Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Dagui Lin. A scholar is included among the top collaborators of Dagui Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dagui Lin. Dagui Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Lin, Dagui, Yulin Huang, Shasha Yin, et al.. (2025). Clock gene ARNTL2 enhances 5-fluorouracil resistance in colon cancer by upregulating SLC7A11 to suppress ferroptosis. Redox Biology. 86. 103798–103798.
2.
Wang, Xiaonan, Dagui Lin, Dingbo Shi, et al.. (2024). FLI1 promotes IFN-γ-induced kynurenine production to impair anti-tumor immunity. Nature Communications. 15(1). 4590–4590. 23 indexed citations
3.
Fan, Wenhua, Dagui Lin, Yuanyuan Xiong, et al.. (2024). Circulating tumor DNA analysis predicts recurrence and avoids unnecessary adjuvant chemotherapy in I–IV colorectal cancer. Therapeutic Advances in Medical Oncology. 16. 2665343–2665343. 3 indexed citations
4.
Liu, Zhihao, Huali Li, Dagui Lin, et al.. (2023). Identification and validation of a novel stress granules-related prognostic model in colorectal cancer. Frontiers in Genetics. 14. 1105368–1105368.
5.
6.
Chen, Yongjian, Yunfang Yu, Jing‐Yun Wen, et al.. (2021). Prognostic and immunological role of CD36: A pan-cancer analysis. Journal of Cancer. 12(16). 4762–4773. 32 indexed citations
7.
Lin, Dagui, Wenhua Fan, Rongxin Zhang, et al.. (2021). Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer. Journal of Translational Medicine. 19(1). 279–279. 42 indexed citations
8.
Huang, Chengmei, Xiaoning Chen, Yaxin Zhang, et al.. (2021). Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC. Journal of Experimental & Clinical Cancer Research. 40(1). 304–304. 67 indexed citations
9.
Zhou, Haiyu, Shaopeng Zheng, Anlin Li, et al.. (2020). Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study). EClinicalMedicine. 24. 100422–100422. 17 indexed citations
10.
Ou, Qiyun, Yunfang Yu, Anlin Li, et al.. (2020). Association of survival and genomic mutation signature with immunotherapy in patients with hepatocellular carcinoma. Annals of Translational Medicine. 8(5). 230–230. 18 indexed citations
11.
Li, Anlin, Yongjian Chen, Qiyun Ou, et al.. (2020). Joint association of patients’ sex and PD‐L1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers. SHILAP Revista de lepidopterología. 10(2). e92–e92. 7 indexed citations
12.
Yu, Yunfang, Dagui Lin, Anlin Li, et al.. (2020). Association of Immune Checkpoint Inhibitor Therapy With Survival in Patients With Cancers With MUC16 Variants. JAMA Network Open. 3(6). e205837–e205837. 13 indexed citations
13.
14.
Yu, Yunfang, Dongqiang Zeng, Qiyun Ou, et al.. (2019). Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non–Small Cell Lung Cancer. JAMA Network Open. 2(7). e196879–e196879. 200 indexed citations
15.
Ou, Qiyun, et al.. (2018). Comprehensive analyses of the clinical benefits of immune checkpoint inhibitors in advanced non-small cell lung cancer.. Journal of Clinical Oncology. 36(5_suppl). 168–168. 1 indexed citations
16.
Yu, Yunfang, et al.. (2018). Comparative efficacy and acceptability of first-line single-agent chemotherapy in metastatic breast cancer.. Journal of Clinical Oncology. 36(15_suppl). e13082–e13082. 1 indexed citations
17.
Yu, Yunfang, et al.. (2018). Benefits and risks from maintenance therapy after first-line chemotherapy in patients with metastatic breast cancer.. Journal of Clinical Oncology. 36(15_suppl). 1088–1088. 1 indexed citations
18.
Yao, Herui, et al.. (2018). Role of neoadjuvant chemotherapy or chemoradiotherapy in oesophageal carcinoma.. Journal of Clinical Oncology. 36(15_suppl). 4040–4040. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiliang Cong Breakdown of academic impact, for papers by Jun Osugi Breakdown of academic impact, for papers by Yuqiu Xu Breakdown of academic impact, for papers by Zhenkui Pan Breakdown of academic impact, for papers by Yunjian Huang Breakdown of academic impact, for papers by Yunfu Deng Breakdown of academic impact, for papers by Fucun Xie Breakdown of academic impact, for papers by Yueyun Chen Breakdown of academic impact, for papers by Maria Saigí Breakdown of academic impact, for papers by De Sen Wan
Rankless by CCL
2026